Daisy Franco
Family · Los Angeles, CANPI 1518277508
Payments from drug & device makers
Across 294 payments — averaging $22.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- IBSA Pharma Inc.$1K
- Collegium Pharmaceutical, Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Nevro Corp.$233
- Amgen$228
- Redhill Biopharma Inc.$225
- plus $2K from 23 others
What the payments were for
- Food & beverage$6,571100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| IBSA Pharma Inc. | 61 | $1,387 |
| Collegium Pharmaceutical, Inc. | 72 | $1,364 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 73 | $1,117 |
| Nevro Corp. | 9 | $233 |
| Amgen(2 entities) | 6 | $228 |
| Redhill Biopharma Inc. | 12 | $225 |
| Boston Scientific | 11 | $212 |
| Abbott | 3 | $209 |
| Scilex Pharmaceuticals Inc. | 12 | $206 |
| AbbVie | 5 | $172 |
| Biodelivery Sciences International, Inc. | 7 | $157 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Novo Nordisk | 1 | $125 |
| Argenx US, Inc. | 1 | $122 |
| Corcept Therapeutics | 1 | $117 |
| Neurocrine Biosciences, Inc. | 1 | $114 |
| Valinor Pharma, LLC | 4 | $85 |
| GRT US Holding, Inc. | 2 | $74 |
| Emergent Biosolutions Inc. | 1 | $45 |
| Organogenesis Inc. | 1 | $40 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Alkermes, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Arbor Pharmaceuticals, Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $24 |
| Impel Pharmaceuticals Inc. | 1 | $23 |
| Virtus Pharmaceuticals LLC | 1 | $21 |
| GSK | 1 | $20 |
| Biotronik NRO, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,571 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 77 | $65,355 |
| NucyntaTapentadol Hcl | 11 | $21,331 |
| MovantikNaloxegol Oxalate | 38 | $20,771 |
| LyricaPregabalin | 11 | $19,057 |
| OxycontinOxycodone Hcl | 13 | $17,054 |
| Nucynta ErTapentadol Hcl | 11 | $15,418 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 424 | $5,760 |
| Buprenorphine | 12 | $5,674 |
| Diclofenac Sodium | 24 | $5,418 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 134 | $2,990 |
| Morphine Sulfate ErMorphine Sulfate | 133 | $2,270 |
| Pregabalin | 108 | $2,247 |
| Hydromorphone ErHydromorphone Hcl | 11 | $1,903 |
| Gabapentin | 137 | $1,755 |
| Oxycodone Hcl | 98 | $1,683 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta, Nucynta Er | $1,364 | $102,10499 claims |
| Redhill Biopharma Inc.Movantik | $225 | $20,77138 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.
Other family in Los Angeles
- Annette ShonLos Angeles$406K
- Phyllis CasonLos Angeles$187K
- Theodore SolomonLos Angeles$131K
- Angela SarffLos Angeles$51K
- Karla MenjivarLos Angeles$36K
- Janet GripshoverLos Angeles$30K
- Jualynda SmithLos Angeles$28K
- Phoebedel ReyesLos Angeles$26K
- Lori RobertsonChino Hills$475K
- Nancy GardettoSan Diego$394K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.